Form 8-K - Current report:
SEC Accession No. 0001104659-20-019696
Filing Date
2020-02-13
Accepted
2020-02-13 07:14:26
Documents
14
Period of Report
2020-02-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm207724d1_8k.htm   iXBRL 8-K 26636
2 EXHIBIT 99.1 tm207724d1_ex99-1.htm EX-99.1 245870
6 GRAPHIC tm207724d1_ex99-1img001.jpg GRAPHIC 8032
  Complete submission text file 0001104659-20-019696.txt   481773

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA incy-20200213.xsd EX-101.SCH 3180
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE incy-20200213_lab.xml EX-101.LAB 34591
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE incy-20200213_pre.xml EX-101.PRE 22706
13 EXTRACTED XBRL INSTANCE DOCUMENT tm207724d1_8k_htm.xml XML 3492
Mailing Address 1801 AUGUSTINE CUT-OFF WILMINGTON DE 19803
Business Address 1801 AUGUSTINE CUT-OFF WILMINGTON DE 19803 3024986700
INCYTE CORP (Filer) CIK: 0000879169 (see all company filings)

EIN.: 943136539 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12400 | Film No.: 20606926
SIC: 8731 Services-Commercial Physical & Biological Research